Should You Buy At This Valuation? – Conatus Pharmaceuticals Inc. (CNAT), The Boeing Company (BA) – Post Analyst

This post was originally published on this site

Should You Buy At This Valuation? – Conatus Pharmaceuticals Inc. (CNAT), The Boeing Company (BA)  Post Analyst

Investors making a wish list of stocks to watch should take a look at Conatus Pharmaceuticals Inc. (NASDAQ:CNAT). The stock is offering a price-to-sales ratio of …

This post was originally published on *this site*